, associate professor of
medicine and medical director, liver transplantation, Department of
Medicine, Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, who presented the data. "Boceprevir has been well tolerated by patients in this study, including in the longer duration treatment arms, and we look forward to further results from this ongoing study."
Overall, 77 percent of the 595 patients in the study were enrolled in the United States.